ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

4 links0 made here, not in the record6 judgments2 judges (the rules as one: Rule based)4 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05765851A Study of DS-1103aCombination Therapy inParticipants With AdvancedSolid TumorsDaiichi SankyoPhase 1 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 15 · ClinicalTrials.gov record · Version of 2026-10-15Oct 22 · ClinicalTrials.gov record · Version of 2026-10-22Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Version of 2026-10-26CONDITIONSAdvanced Solid TumorNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSINT011844Entry “DS-1103a”, read by our name ru…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumab deruxtecanEntry “T-DXd”, read by our name rule›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT011844

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “DS-1103a”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Oct 15The record itselfClinicalTrials.gov recordVersion of 2026-10-15Record change
Oct 22The record itselfClinicalTrials.gov recordVersion of 2026-10-22Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Nov 2INT011844Claude Opus 5.5TestedCurrent
Nov 2Trastuzumab deruxtecanClaude Opus 5.5Background · partnerCurrent
Nov 2TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 14Advanced Solid TumorRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18INT011844Rule based · role ruleTestedAgrees
Nov 18Trastuzumab deruxtecanRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.